On one hand, it promotes tumor progression through non-immune mechanisms, while on the other hand, it leads to CD8 T cell functional depletion by up-regulating TRIM14 to continuously activate the TBK1-IFNβ pathway. The gene discussed is CD8A; the disease is neoplasm.